These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Steroid therapy for neurologic diseases--indications and methods of administration]. Takatsu M; Toyokura Y Nihon Rinsho; 1979 Jun; 37(6):1308-15. PubMed ID: 225590 [No Abstract] [Full Text] [Related]
26. [Therapeutic experiences with a combination of oxyphenbutazone and prednisolone in diseases of the locomotor system]. Lobsiger M; Gabel H Schweiz Rundsch Med Prax; 1973 Apr; 62(15):482-5. PubMed ID: 4571937 [No Abstract] [Full Text] [Related]
27. [Preliminary results with a new corticosteroid for topical use]. de Abreu JG Hospital (Rio J); 1970 Apr; 77(4):1197-200. PubMed ID: 4939508 [No Abstract] [Full Text] [Related]
29. Chronobiological pattern of growth hormone secretion in normal subjects and in retinopathic diabetics. Lack of suppression by a plurichronocorticoid drug. Muggeo M; Molinari M; Baiocchi A; Tiengo A; Fedele D; Crepaldi G Chronobiologia; 1976; 3(4):323-34. PubMed ID: 1030662 [TBL] [Abstract][Full Text] [Related]
30. 25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man. Nuti R; Vattimo A; Turchetti V; Righi G J Endocrinol Invest; 1984 Oct; 7(5):445-8. PubMed ID: 6239890 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of epidermal growths with solcoderm]. Haim S; Cohen A Harefuah; 1983 Feb; 104(3):89-90. PubMed ID: 6352426 [No Abstract] [Full Text] [Related]
32. Prednimustine in mycosis fungoides: a report from the Scandinavian mycosis fungoides study group. Molin L; Thomsen K; Volden G; Bergqvist-Karlsson A; Hellbe L Acta Derm Venereol; 1979; 59(1):87-8. PubMed ID: 84481 [TBL] [Abstract][Full Text] [Related]
33. [Isolated ACTH deficiency and transient GH deficiency. Presentation of a case]. Vincenzi P; Francia G; Dorizzi R; Pedrazzoli R; Lazzarin M Minerva Endocrinol; 1992; 17(3):127-31. PubMed ID: 1338549 [TBL] [Abstract][Full Text] [Related]
34. [Diucifon in the therapy of dermatoses]. Grebeniuk VN; Fedorova EG; Sheklakova MN Vestn Dermatol Venerol; 1980 Feb; (2):41-3. PubMed ID: 6986724 [No Abstract] [Full Text] [Related]
35. [Clinical evaluation of the preparations Baycuten and Baycuten SD produced by Bayer]. Polkowska M Przegl Dermatol; 1984; 71(5):483-6. PubMed ID: 6396736 [No Abstract] [Full Text] [Related]
36. [Clinical experiences with realin (oxyphenbutazone and prednisolone) in progressive chronic polyarthritis]. Klein G; Fellner S Z Rheumaforsch; 1973; 32(7):302-5. PubMed ID: 4741803 [No Abstract] [Full Text] [Related]
37. [Study of skin absorption of water soluble corticosteroid preparation, depersolon, in healthy persons and patients with skin diseases]. Kiraĭ K; Massi I; Kosef O; Fekher G; Fiulep E Vestn Dermatol Venerol; 1975 Jan; (1):30-8. PubMed ID: 1136579 [No Abstract] [Full Text] [Related]
38. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone]. Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580 [TBL] [Abstract][Full Text] [Related]
39. Clinical study of the relationship between dose and response to halopredone acetate in dermatoses. Rampini E; Rastelli A; Divano C Arzneimittelforschung; 1977; 27(12):2399-403. PubMed ID: 341904 [TBL] [Abstract][Full Text] [Related]
40. [Contribution on the local application of corticosteroids]. Schieferstein G Z Haut Geschlechtskr; 1966 Nov; 41(9):354-63. PubMed ID: 5995307 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]